Patents
Patents for C07C 251 - Compounds containing nitrogen atoms doubly- bound to a carbon skeleton (9,928)
09/2005
09/01/2005US20050191567 Oxime ester photoinitiators
09/01/2005CA2558064A1 Contrast medium for thrombus formation
09/01/2005CA2555261A1 Management of ophthalmologic disorders, including macular degeneration
08/2005
08/31/2005CN1660786A Stabilization method of cycloalkanone oxime
08/31/2005CN1660785A Process for producing oxime
08/31/2005CN1216533C Ectoparasitic insect pest controllers for animals and their usage
08/30/2005US6936719 pyridine ring containing biaryl compound useful to treat and/or prevent clotting disorders, and as antiinflammatory and anticoagulant agents
08/24/2005EP1566385A1 Phosphorescent compound and electroluminescent element including the same
08/24/2005EP1565427A1 Process for the preparation of an enantiomerically enriched schiff base
08/24/2005CN1659154A Method of preparing amine stereoisomers
08/24/2005CN1216040C 3-Cyan-2,4,5-trifluoro benzoyl fluoride and intermediate produced therefor
08/23/2005US6933400 Coordination polymerization catalyst
08/23/2005US6933319 Resorcinol derivatives
08/23/2005US6933307 Fungicidal phenylimine derivatives
08/23/2005CA2469592C Hiv integrase inhibitors
08/23/2005CA2153235C Compounds having selectivity for retinoid x receptors
08/18/2005WO2005075501A1 Polyoxyalkylene compound and method for making
08/18/2005US20050182120 Fungicides, microbiocides
08/17/2005CN1656059A Diimonium salt mixtures, aminium salts mixtures and use thereof
08/17/2005CN1655774A Bis-aromatic alkanols
08/17/2005CN1654459A Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof
08/17/2005CN1215051C Ester compounds
08/17/2005CN1215050C Method for production of trioxime derivatives
08/16/2005US6930208 3-Keto- or 3- oxime-ether-substituted benzoylcyclohexanediones
08/16/2005US6930204 comprises subjecting a cyclic aliphatic primary amine to oxidation in the liquid phase under superatmospheric pressure in the presence of molecular oxygen and a solid catalyst
08/16/2005CA2232374C Phenylacetic acid derivatives, processes and intermediates for their preparation, and compositions comprising them
08/11/2005WO2005073196A1 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING α-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME
08/11/2005WO2005000233A3 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
08/11/2005US20050176990 Catalysis with transition metal and nitrogen on a carbon support, producing N-(phosphonomethyl)glycine
08/11/2005US20050176989 Oxidation of N-(phosphonomethyl)iminodiacetic acid with an oxidizing agent and a catalyst of a carbon support having nitrogen and carbon
08/10/2005EP1399406B1 Novel estrogen receptor ligands and methods i
08/10/2005CN1653037A Substituted tetracycline compounds
08/10/2005CN1653025A NK1 antagonists
08/10/2005CN1651405A Method of synthesizing butanone oxime
08/10/2005CN1651404A Aryl imine cocrystalization compound, its synthesis and application
08/10/2005CN1214001C Insecticiding agent diphenylmethanone hydazone derivative
08/10/2005CN1213993C Method for separating imine from mixture containing amine and imine
08/09/2005US6927308 Method for synthesis of oximes
08/04/2005US20050171002 Polyoxyalkylene compound and method for making
08/04/2005US20050170092 Alkaline earth metal complexes and their use
08/03/2005EP1305284A4 Process and intermediate compounds for the preparation of pyrrolidines
08/03/2005CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
08/03/2005CN1649829A Novel florfenicol-type antibiotics
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/28/2005WO2005068415A1 Phenylalanine derivative
07/28/2005US20050165240 Chemical intermediates for production of sibutramine
07/28/2005US20050165114 Antiinflammatory agent, immunosuppressant, anticancer agents, antiarthritic agents; AP-1 activation inhibitor, NF-kappa B activation inhibitor
07/28/2005US20050165095 preventing, treating or ameliorating retinoid poisoning, overdose by a retinoid; e.g. E-4-[3-(8,8-Dimethyl-5-p-tolyl-7,8-dihydro-naphthalen-2-yl)-3-hydroxyimino-propenyl]-benzoic acid (Compound 7a) and Z-4-[3-(8,8-dimethyl-5-p-tolyl-7,8-dihydro-naphthalen-2-yl)-3-hydroxyimino-propenyl]-benzoic Acid
07/28/2005US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
07/27/2005CN1646472A Analogous compounds of strobilurines and their use as acaricides and insecticides
07/26/2005CA2380864C Fungicidal compounds having a fluorovinyl- or fluoropropenyl-oxyphenyloxime moiety and process for the preparation thereof
07/21/2005WO2005066116A1 Disubstituted chalcone oximes as selective agonists of rarϝ retinoid receptors
07/21/2005WO2005066115A2 Disubstituted chalcone oximes having rarϝ retinoid receptor antagonist activity
07/21/2005US20050158581 Polymers having attached luminescent metal complexes and devices made with such polymers
07/21/2005US20050158479 Volatile copper(II) complexes and reducing agents for deposition of copper films by atomic layer deposition
07/21/2005CA2552090A1 Disubstituted chalcone oximes as selective agonists of rar.gamma. retinoid receptors
07/21/2005CA2551294A1 Disubstituted chalcone oximes having rary retinoid receptor antagonist activity
07/20/2005EP1230211B1 Process for the preparation of ketimines
07/20/2005CN1640868A Substituted benzol acetone oxime derivative and its preparing method and use
07/20/2005CN1211353C Unsaturated hydroximic acid derivatives as PARP inhibitors
07/20/2005CN1211352C Cyclohexenone oxime ether metal salts
07/19/2005US6919462 Using 1-aryl-3-cyano-5-aminopyrazole compound
07/19/2005US6919449 Process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds
07/14/2005WO2005063840A1 Non-fugitive catalysts containing imine linkages and tertiary amines, and polyurethane products made therefrom
07/14/2005WO2005063692A1 (hetero)cyclyl carboxanilides for controlling harmful fungi
07/14/2005WO2005063691A1 Coammoxidation of ketones
07/14/2005WO2005063665A1 Propofol analogs, process for their preparation, and methods of use
07/14/2005WO2005063222A1 Hsp90 FAMILY PROTEIN INHIBITOR
07/14/2005WO2005063018A1 Haloalkene compounds, process for their production and pesticides containing them
07/14/2005US20050154056 Inhibitors of HCV NS5B polymerase
07/14/2005DE10357044A1 Verfahren zur Dotierung von organischen Halbleitern mit Chinondiiminderivaten Method for doping of organic semiconductors with Chinondiiminderivaten
07/14/2005CA2551567A1 Propofol analogs, process for their preparation, and methods of use
07/14/2005CA2549846A1 Non-fugitive catalysts containing imine linkages and tertiary amines, and polyurethane products made therefrom
07/14/2005CA2540254A1 Coammoxidation of ketones
07/13/2005CN1639128A O-cyclopropyl-carboxanilides and their use as fungicides
07/13/2005CN1639113A Method for producing 2-chloromethylphenyl acetic acid derivatives
07/13/2005CN1639096A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
07/13/2005CN1637626A Organophotoreceptor with a charge transport material having at least three linked hydrazone groups
07/13/2005CN1636971A Oxime derivatives and the use thereof as latent acids
07/12/2005US6916893 A nickel coordination catalyst for forming polyethylene, polycrystalline, branching or linear polyolefins
07/12/2005US6916850 Pyruvate derivatives
07/07/2005WO2005061501A2 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
07/07/2005WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
07/07/2005US20050148786 Nontoxic; heat, moisture and light resistance; solubility; infrared absorption filter, optical information recording medium; antimony and arsenic free
07/07/2005US20050148590 4-[3-Hydroxyimino-3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-propenyl]-benzoic acid; emphysema; respiratory system and skin disorder; acne and psoriasis; side effect reduction; improved pharmacology
07/07/2005US20050147903 Organophotoreceptor with a charge transport material having at least three linked hydrazone groups
07/07/2005DE10358956A1 New metal chelates of beta-ketiminate ligands, useful for depositing thin metal-containing layers, e.g. for electronic components
07/07/2005DE10355358A1 Mixtures for use in organic electronic devices of simplified layer structure comprise matrix materials (some of which in e.g. (hetero)aromatic ketone form are new) and emitters containing an element of atomic number above 20
07/07/2005CA2547159A1 Process for preparing hexahydropyrimido[1,2-a]azepine-2-carboxylates and related compounds
07/06/2005EP1550653A1 Organophotoreceptor with a charge transport material having at least three linked hydrazone groups
07/06/2005EP1550652A2 Stabilization method of cycloalkanone oxime
07/06/2005CN1636007A Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
07/05/2005CA2230082C Amide compounds and use thereof
06/2005
06/30/2005WO2005044899A8 Prepolymer, prepolymer composition, high molecular weight polymer having structure containing hole and electrically insulating film
06/30/2005US20050139810 dopes used in electronic component structures, such as light emitting diodes (OLEDs), field effect transistors (FETs) or solar cells
06/29/2005EP1548000A1 Process for producing oxime
06/29/2005EP1545772A2 Nitrogen-containing ligands
06/28/2005US6911478 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
06/23/2005US20050137423 Process for producing oxime
06/23/2005US20050137192 Use of compounds such as 4-bromo-9a-butyl-8-chloro-6-fluoro-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one to treat depression
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 100